A procedure called “uterine morcellation” has allegedly caused serious injuries in some women, and now those women are fighting back. A number of new lawsuits have been filed against manufacturers of electric or power morcellators. These surgical instruments are used to mince up tissues for…
Risperdal (risperidone), an anti-psychotic drug, was initially approved by the FDA for use in adults in 1993. It wasn’t cleared for use in children until 2006, though some doctors prescribed it “off-label” to treat symptoms of schizophrenia, autism, and bipolar disorder. That same year, researchers…
The Journal of the American Medical Association (JAMA) reported in March 2014 that between 1983 and 2010, a total of 13 women developed unexpected uterine cancer after having gone through uterine surgery. In most cases, fibroids are benign tumors that grow in the uterus. They…
Recent studies have suggested that Risperdal (risperidone), a medication prescribed to treat schizophrenia and bipolar disorder, can cause serious side effects, including abnormal breast development in boys and teens (gynecomastia). Over 400 individuals who used Risperdal and then experienced allege
Over 400 Risperdal lawsuits have been filed against drug maker Janssen Pharmaceuticals and parent company, Johnson & Johnson (J&J). Over 100 of those involve claims of “gynecomastia,” or abnormal breast enlargement in males. How is this antipsychotic drug tied to gynecomastia? Risperidone Prescribed
Risperdal manufacturer Johnson & Johnson (J&J) faces over 400 lawsuits alleging it failed to warn patients and healthcare providers about the serious side effects of the drug. Now, according to court documents, another Risperdal lawsuit has been filed in the Southern District of California. Benjamin
In 2006, a study by researchers at Duke University reported that Risperdal could cause gynecomastia—breast growth in males. Adolescents who took Risperdal exhibited significantly higher levels of “prolactin,” a hormone that stimulates breast development in women. After that, several more studies fou
An antipsychotic drug, Risperdal, was first marketed and FDA-approved to treat schizophrenia in adults in 1993. In 2003, it was approved to treat bipolar disorder, autism in children and teens in 2006 and in 2007 for children with schizophrenia, followed by an approval of the…
It is one of the largest health care fraud settlements in United States history. Janssen Pharmaceuticals Inc., and Johnson & Johnson, the parent company of the antipsychotic drug, Risperdal, will pay more than $2.2 billion in criminal and civil investigations. It was alleged that from…
Risperdal (risperidone) was the first antipsychotic drug marketed in the U.S. after clozapine. It was approved to treat schizophrenia in adults in 1993. The drug has since been linked to an increased risk for diabetes. A 2003 study published in the National Center for Biotechnology…
Risperdal, manufactured by Johnson & Johnson and its Janssen Pharmaceuticals subsidiary was approved for use by the FDA in 1993 to treat schizophrenia. Since then it was approved for use in 2003 for bipolar disorder, in 2006 for irritability in children and teenagers with autism,…
On November 18, 2013, Bloomberg reported that Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson (J&J), was ordered by a Philadelphia jury to pay $11 million in a recent Topamax lawsuit. The plaintiffs claimed the anti-seizure drug caused their child to suffer from serious birth…
